Literature DB >> 17916922

Trace element concentration in primary liver cancers--a systematic review.

Kurinchi Gurusamy1.   

Abstract

BACKGROUND: The incidence of primary liver cancer varies between countries. Many of the etiological factors contributing to the geographical variations in incidence are unknown. Development of hepatocellular carcinoma has been linked to levels of trace elements. This review summarizes the evidence associating HCC with trace elements.
METHODS: MEDLINE, EMBASE, and CENTRAL databases were searched. Various inclusion and exclusion criteria were applied to select the articles for inclusion. Data extraction was performed using a custom designed data extraction form.
RESULTS: A total of 12,344 references were identified. Duplicates, 1,597, were excluded. Clearly irrelevant references, 10,676, were excluded through reading titles and abstracts. Some references (59) were excluded by applying the exclusion criteria. Twelve studies including 646 patients and measuring iron content (8), copper content (11), zinc (9), and selenium (2) qualified for the review. Although a meta-analysis was not possible due to heterogeneity between the studies, a clear pattern of distribution of the trace elements was discernible.
CONCLUSION: Iron and zinc content are lower in HCC than in surrounding tissues or normal controls. Copper content is lower in HCC than in surrounding tissues and cirrhotic controls. Epidemiological and physiological reasons for the trace element alterations should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916922     DOI: 10.1007/s12011-007-0008-x

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  14 in total

Review 1.  Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Expert Rev Anticancer Ther       Date:  2012-01       Impact factor: 4.512

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

3.  Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration.

Authors:  Benjamin P Weaver; Yuxia Zhang; Stephen Hiscox; Grace L Guo; Udayan Apte; Kathryn M Taylor; Christian T Sheline; Li Wang; Glen K Andrews
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

4.  Changes of Serum Trace Elements, AFP, CEA, SF, T3, T4 and IGF-II in Different Periods of Rat Liver Cancer.

Authors:  Hong-Xu Zhang; Dan-Dan Liu; Bai-Jie Jin; Ya-Wei Wang; Qi Liu; Ru-Bing Duan; Peng Zhao; Ming-Xia Ma
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

Review 5.  The important role of the apoptotic effects of zinc in the development of cancers.

Authors:  Renty B Franklin; Leslie C Costello
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

Review 6.  Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response.

Authors:  Jill S Gluskin; Fabrizio Chegai; Serena Monti; Ettore Squillaci; Lorenzo Mannelli
Journal:  J Cancer       Date:  2016-07-13       Impact factor: 4.207

7.  Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cells.

Authors:  Luis Cano; Stéphane Bertani; Marie-Laure Island; Juan Pablo Cerapio; Eloy Ruiz; Pascal Pineau; Valérie Monbet; Karim Boudjema; Luis Taxa; Sandro Casavilca-Zambrano; Martine Ropert; Bruno Turlin; Olivier Loréal
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

8.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

9.  A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.

Authors:  Hephzibah Rani S Tagaram; Dhimant Desai; Guangfu Li; Dai Liu; C Bart Rountree; Kavitha Gowda; Arthur Berg; Shantu Amin; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal:  Pharmaceuticals (Basel)       Date:  2016-03-24

Review 10.  Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Nutrients       Date:  2018-01-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.